Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 5:01 pm Purchase | 13G | ImmunoGen Inc. IMGN | RA CAPITAL MANAGEMENT L.P. | 26,916,027 9.990% | 4,840,869 (+21.93%) | View |
2024-02-14 4:26 pm Sale | 13G | ImmunoGen Inc. IMGN | Redmile Group LLC | 16,423,922 5.900% | -3,472,531 (-17.45%) | View |
2024-02-13 5:06 pm Purchase | 13G | ImmunoGen Inc. IMGN | VANGUARD GROUP INC | 25,466,950 9.130% | 11,088,515 (+77.12%) | View |
2024-02-07 07:56 am Sale | 13G | ImmunoGen Inc. IMGN | ADAGE CAPITAL PARTNERS GP L.L.C. | 971,928 0.350% | -10,147,072 (-91.26%) | View |
2024-01-25 4:59 pm Purchase | 13G | ImmunoGen Inc. IMGN | BlackRock Inc. BLK | 21,823,243 8.200% | 3,807,241 (+21.13%) | View |
2024-01-22 09:50 am Sale | 13G | ImmunoGen Inc. IMGN | STATE STREET CORP STT | 8,075,671 3.020% | -9,432,442 (-53.87%) | View |
2023-02-14 4:45 pm Sale | 13G | ImmunoGen Inc. IMGN | RA CAPITAL MANAGEMENT L.P. | 22,075,158 9.990% | -87,800 (-0.40%) | View |
2023-02-14 4:20 pm Purchase | 13G | ImmunoGen Inc. IMGN | Redmile Group LLC | 19,896,453 8.600% | 274,472 (+1.40%) | View |
2023-02-10 09:44 am Sale | 13G | ImmunoGen Inc. IMGN | Flynn James E | 6,358,314 2.880% | -8,421,276 (-56.98%) | View |
2023-02-09 11:22 am Sale | 13G | ImmunoGen Inc. IMGN | VANGUARD GROUP INC | 14,378,435 6.510% | -753,317 (-4.98%) | View |
2023-02-09 11:18 am Sale | 13G | ImmunoGen Inc. IMGN | FMR LLC | 1,197,223 0.542% | -11,077,599 (-90.25%) | View |
2023-02-08 1:59 pm Purchase | 13G | ImmunoGen Inc. IMGN | STATE STREET CORP STT | 17,508,113 7.930% | 12,161,687 (+227.47%) | View |
2023-02-06 2:53 pm Sale | 13G | ImmunoGen Inc. IMGN | WELLINGTON MANAGEMENT GROUP LLP | 9,226,708 4.180% | -4,675,790 (-33.63%) | View |
2023-02-03 4:27 pm Purchase | 13G | ImmunoGen Inc. IMGN | BlackRock Inc. BLK | 18,016,002 8.200% | 3,152,698 (+21.21%) | View |
2022-12-27 4:30 pm Sale | 13G | ImmunoGen Inc. IMGN | ADAGE CAPITAL PARTNERS GP L.L.C. | 11,119,000 5.040% | -467,193 (-4.03%) | View |
2022-05-19 4:50 pm Purchase | 13G | ImmunoGen Inc. IMGN | Flynn James E | 14,779,590 6.700% | 14,779,590 (New Position) | View |
2022-04-04 4:30 pm Purchase | 13G | ImmunoGen Inc. IMGN | ADAGE CAPITAL PARTNERS GP L.L.C. | 11,586,193 5.250% | 11,586,193 (New Position) | View |
2022-03-11 2:13 pm Unchanged | 13G | ImmunoGen Inc. IMGN | BlackRock Inc. BLK | 14,863,304 6.900% | 0 (Unchanged) | View |
2022-02-14 5:07 pm Purchase | 13G | ImmunoGen Inc. IMGN | Redmile Group LLC | 19,621,981 8.500% | 9,093,802 (+86.38%) | View |
2022-02-14 4:11 pm Purchase | 13G | ImmunoGen Inc. IMGN | RA CAPITAL MANAGEMENT L.P. | 22,162,958 9.990% | 3,745,500 (+20.34%) | View |